Skip to content
  • Home
  • Project
  • Partners
  • News
  • Events
  • Publications
  • Contact
  • Intranet

Publications

European Society for Alternatives to Animal Testing (EUSAAT) 2024 congress in Linz, Austria
08.10.2024
Exploring the safety of cannabidiol (CBD): A comprehensive in vitro evaluation of the genotoxic and mutagenic potential of a CBD isolate and extract from Cannabis sativa L
07.10.2024
Patient-derived tumor organoids mimic treatment-induced DNA damage response in glioblastoma
21.08.2024
EACR congress in Rotterdam June 2024
20.06.2024
Hepatic 3D cell model : a sensitive approach for determining the adverse (geno)toxic activity of air pollutants
12.06.2024
Assessment of the (geno)toxic potential of Vanadium-doped iron-oxide nanozymes in vitro.
12.06.2024
Brain tumour meeting 2024
11.06.2024
Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer
04.06.2024
Genotoxicity and heating Performance of VxFe3-xO4 nanoparticles in Health applications
04.06.2024
Adverse (geno)toxic effects of bisphenol A and its analogues in hepatic 3D cell model
04.06.2024
←1234→

Discover More About the Project

The overarching aim of CutCancer is to improve the scientific excellence and innovation capacity in the field of 3D in vitro cancer research at the National Institute of Biology, Slovenia.

Discover methodology

Twinning for excellence to strategically advance research in carcinogenesis and cancer.

  • Home
  • Project
  • Partners
  • Events
  • Publications
  • Contact
eu-logo

This project has received funding from the European Union’s Horizon Europe Research and Innovation Program under Grant Agreement No 101079113 and the UK Research and Innovation (UKRI) under the UK government’s Horizon Europe funding guarantee under Grant No 10050740.

uk-research-logo
© 2023 Cut Cancer. All rights reserved. | Made by GC.
Terms & conditions
Contact
Go to Top
  • Home
  • Project
  • Partners
  • News
  • Events
  • Publications
  • Contact
  • Intranet